Comparison of the efficacy of ciclesonide 160 μg QDand budesonide 200 μg BID in adults with persistent asthma: A phase III, randomized, double-dummy, open-label study

@article{Niphadkar2005ComparisonOT,
  title={Comparison of the efficacy of ciclesonide 160 $\mu$g QDand budesonide 200 $\mu$g BID in adults with persistent asthma: A phase III, randomized, double-dummy, open-label study},
  author={P. Niphadkar and K. Jagannath and J. Joshi and N. Awad and H. Boss and S. Hellbardt and D. Gadgil},
  journal={Clinical Therapeutics},
  year={2005},
  volume={27},
  pages={1752-1763}
}
Abstract Objective: The efficacy of ciclesonide 160 μg QD (given either in the morning or evening) was compared with budesonide 200 μg BID in adults with stable asthma that was pretreated with inhaled corticosteroids. Methods: This was a randomized, 3-arm, parallel-groupstudy comparing ciclesonide (given in a double-blind, double-dummy regimen) with open-label budesonide. After 2 to 2.5 weeks, during which patients were treated with budesonide 200 μg BID, patients (n = 405) were randomly… Expand
Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
Profile of ciclesonide for the maintenance treatment of asthma
...
1
2
3
4
...

References

SHOWING 1-10 OF 25 REFERENCES
Systemic effect comparisons of six inhaled corticosteroid preparations.
Once-daily inhaled corticosteroids for the treatment of asthma
  • L. Boulet
  • Medicine
  • Current opinion in pulmonary medicine
  • 2004
Side effects of inhaled corticosteroids.
  • J. Toogood
  • Medicine
  • The Journal of allergy and clinical immunology
  • 1998
Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs.
Population Pharmacokinetics and Pharmacodynamics of Ciclesonide
Inhaled corticosteroids: past lessons and future issues.
...
1
2
3
...